日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial"

更正:“在QuANTUM-First试验中,造血细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响”

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P

FLT3-ITD measurable residual disease from the QuANTUM-First trial

Quantum-First试验中FLT3-ITD可测量残留病灶

Levis, Mark J; Erba, Harry P; Montesinos, Pau; Kim, Hee-Je; Vrhovac, Radovan; Patkowska, Elżbieta; Žák, Pavel; Wang, Po-Nan; Connolly Rohrbach, Jaime E; Chang, Ken C N; Liu, Li; Mostafa Kamel, Yasser; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Hervé; Amadori, Sergio; Wang, Jianxiang; Schlenk, Richard F; Perl, Alexander E

Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial

在QuANTUM-First试验中,造血干细胞移植和quizartinib对新诊断的伴有FMS样酪氨酸激酶3内部串联重复的急性髓系白血病患者的影响

Schlenk, Richard F; Montesinos, Pau; Kim, Hee-Je; Romero-Aguilar, Antonio; Vrhovac, Radovan; Patkowska, Elżbieta; Žak, Pavel; Wang, Po-Nan; Hanyok, James; Liu, Li; Kamel, Yasser Mostafa; Imadalou, Karima; Lesegretain, Arnaud; Cortes, Jorge; Sekeres, Mikkael A; Dombret, Herve; Amadori, Sergio; Wang, Jianxiang; Perl, Alexander E; Levis, Mark J; Erba, Harry P